Core Insights - Johnson & Johnson (JNJ) reported earnings per share of $2.46, exceeding estimates of $2.43, and revenue of approximately $24.56 billion, surpassing the estimated $24.16 billion [1][5] Group 1: Financial Performance - The company's revenue increased by 9% during the fourth quarter, driven primarily by its cancer and autoimmune drug segments [2][5] - JNJ is positioned to potentially reach $100 billion in revenue next year as part of a new strategic initiative [2] - Despite a drug pricing deal with the Trump administration expected to impact profits by "hundreds of millions of dollars," JNJ remains optimistic about its 2026 sales and profit projections [2] Group 2: Financial Metrics - JNJ has a price-to-earnings (P/E) ratio of approximately 21.10, indicating the price investors are willing to pay for each dollar of earnings [3][5] - The price-to-sales ratio is about 5.71, reflecting the value placed on each dollar of sales [3][5] - The enterprise value to sales ratio stands at around 6.00, suggesting the company's total valuation relative to its sales [3] - The enterprise value to operating cash flow ratio is approximately 22.86, showing how the company's valuation compares to its cash flow from operations [4] - JNJ has an earnings yield of about 4.74%, providing a return on investment for shareholders [4] - The company's debt-to-equity ratio is approximately 0.58, indicating a moderate level of debt relative to equity [4] - A current ratio of around 1.07 suggests JNJ's ability to cover short-term liabilities with short-term assets [4]

Core Viewpoint - The article emphasizes the importance of value investing and highlights SSAB (SSAAY) as a strong candidate for value investors due to its favorable financial metrics and Zacks Rank [1][2][7] Group 1: Company Overview - SSAB (SSAAY) currently holds a Zacks Rank of 2 (Buy) and an A grade for Value, indicating strong potential for value investors [4] - The stock has a P/E ratio of 7.54, significantly lower than the industry average of 11.75, suggesting it may be undervalued [4] - Over the past year, SSAAY's Forward P/E has fluctuated between 6.79 and 14.36, with a median of 8.12 [4] Group 2: Financial Metrics - SSAAY has a P/B ratio of 0.83, which is attractive compared to the industry's average P/B of 1.93, indicating a favorable market value relative to its book value [5] - The P/B ratio for SSAAY has ranged from 0.57 to 1.10 over the past year, with a median of 0.84 [5] - The company also has a P/CF ratio of 6.74, which is appealing when compared to the industry's average P/CF of 19.97, suggesting strong cash flow relative to its valuation [6] - SSAAY's P/CF has varied between 3.33 and 7.71 over the past year, with a median of 6.50 [6] Group 3: Investment Outlook - The financial metrics indicate that SSAB is likely undervalued, and its strong earnings outlook positions it as one of the market's strongest value stocks [7]

Company Performance - Alphabet's stock closed at $322.00, down 2.42%, underperforming the S&P 500's loss of 2.06% [1] - Over the past month, Alphabet's shares gained 6.53%, outperforming the Computer and Technology sector's gain of 1.71% and the S&P 500's gain of 1.63% [1] Upcoming Earnings - Alphabet's earnings report is scheduled for February 4, 2026, with an expected EPS of $2.59, indicating a 20.47% growth year-over-year [2] - Revenue is projected to be $94.6 billion, reflecting a 15.9% increase compared to the same quarter last year [2] Full Year Estimates - For the full year, analysts expect earnings of $10.58 per share and revenue of $340.26 billion, marking changes of +31.59% and 0% respectively from the previous year [3] Analyst Estimates - Recent changes in analyst estimates indicate a positive outlook for Alphabet's business performance and profit potential [4] - The Zacks Rank system, which incorporates these estimate changes, currently ranks Alphabet at 3 (Hold) [6] Valuation Metrics - Alphabet's Forward P/E ratio is 29.88, which is a premium compared to the industry average of 17.85 [7] - The PEG ratio for Alphabet is 1.82, compared to the Internet - Services industry average of 1.76 [7] Industry Ranking - The Internet - Services industry, part of the Computer and Technology sector, has a Zacks Industry Rank of 67, placing it in the top 28% of over 250 industries [8]

Core Viewpoint - Investors in the REIT and Equity Trust - Retail sector should consider Phillips Edison & Company, Inc. (PECO) and Tanger (SKT) as potential investment opportunities, with a closer examination needed to determine which stock offers better value [1] Group 1: Zacks Rank and Value Metrics - Both PECO and SKT currently hold a Zacks Rank of 2 (Buy), indicating positive revisions to their earnings estimates and improving earnings outlooks [3] - Value investors typically assess various traditional metrics, including P/E ratio, P/S ratio, earnings yield, and cash flow per share, to identify undervalued stocks [4] Group 2: Valuation Comparisons - PECO has a forward P/E ratio of 12.92, while SKT has a forward P/E of 13.88, suggesting PECO may be the more attractive option based on this metric [5] - PECO's PEG ratio is 1.39, compared to SKT's PEG ratio of 1.86, indicating that PECO may offer better value when considering expected EPS growth [5] - PECO's P/B ratio is 1.72, significantly lower than SKT's P/B of 5.18, further supporting the argument that PECO is the superior value option [6] - Based on these valuation metrics, PECO holds a Value grade of B, while SKT has a Value grade of C, reinforcing the conclusion that PECO is the better value investment at this time [6]

Core Viewpoint - Bank OZK is set to release its quarterly earnings on January 20, 2026, with analysts projecting an EPS of $1.56 and revenues of approximately $434.3 million, indicating a positive trend in financial performance [1][5]. Financial Performance - The consensus EPS estimate has been revised upwards by 0.1% over the past month, which may influence investor behavior and stock price performance [2]. - The anticipated revenue growth of 4.9% year-over-year suggests a positive trend in the bank's financial performance [5]. Valuation Metrics - The price-to-earnings (P/E) ratio is approximately 7.8, indicating how the market values its earnings [3][5]. - The price-to-sales ratio is about 1.97, reflecting the company's market value relative to its sales [3]. - The enterprise value to sales ratio is around 1.12, suggesting the company's total value compared to its sales [3]. Leverage and Liquidity - The bank's debt-to-equity ratio is approximately 0.13, indicating a relatively low level of debt compared to its equity, which may appeal to investors [4][5]. - The current ratio of around 0.11 may raise liquidity considerations, indicating the company's ability to cover short-term liabilities with its short-term assets [4].

Company Performance - Intuit's stock closed at $554.58, reflecting a decline of -2.12% from the previous day, underperforming the S&P 500 which gained 0.26% [1] - Over the past month, Intuit's shares have decreased by 14.25%, contrasting with the Computer and Technology sector's gain of 1.58% and the S&P 500's gain of 1.57% [1] Upcoming Earnings - Analysts anticipate Intuit will report earnings of $3.65 per share, indicating a year-over-year growth of 9.94% [2] - The expected quarterly revenue is $4.53 billion, representing a 14.23% increase from the same period last year [2] Annual Estimates - For the annual period, earnings are projected at $23.13 per share and revenue at $21.12 billion, reflecting increases of +14.79% and +12.16% respectively from the previous year [3] - Recent changes in analyst estimates for Intuit are crucial as they often indicate near-term business trends, with positive revisions suggesting a favorable business outlook [3] Valuation Metrics - Intuit's Forward P/E ratio stands at 24.5, which is higher than the industry average Forward P/E of 22.53 [6] - The company has a PEG ratio of 1.72, slightly below the average PEG ratio of 1.74 for Computer - Software stocks [6] Industry Context - The Computer - Software industry is part of the broader Computer and Technology sector, which holds a Zacks Industry Rank of 86, placing it in the top 36% of over 250 industries [7] - The Zacks Industry Rank measures the strength of industry groups based on the average Zacks Rank of individual stocks, with the top 50% rated industries outperforming the bottom half by a factor of 2 to 1 [7]

Core Viewpoint - Grupo Cibest (CIB) is currently more attractive to value investors compared to ITT, based on various valuation metrics and earnings outlook [1][7]. Valuation Metrics - CIB has a forward P/E ratio of 9.10, significantly lower than ITT's forward P/E of 24.22 [5]. - The PEG ratio for CIB is 0.91, indicating a more favorable valuation in relation to its expected earnings growth compared to ITT's PEG ratio of 1.92 [5]. - CIB's P/B ratio stands at 2.03, while ITT's P/B ratio is higher at 5.28, suggesting that CIB is undervalued relative to its book value [6]. Earnings Outlook - CIB has a Zacks Rank of 1 (Strong Buy), indicating an improving earnings outlook, while ITT has a Zacks Rank of 3 (Hold) [3][7]. - The positive revisions to earnings estimates for CIB contribute to its favorable position in the Zacks Rank model [3].

Core Viewpoint - Investors in the Retail - Restaurants sector should consider Restaurant Brands (QSR) as a potentially undervalued stock compared to Chipotle Mexican Grill (CMG) [1] Group 1: Zacks Rank and Earnings Outlook - Restaurant Brands has a Zacks Rank of 2 (Buy), indicating a positive earnings estimate revision trend, while Chipotle Mexican Grill has a Zacks Rank of 3 (Hold) [3] - The improving earnings outlook for QSR makes it a more attractive option for value investors [7] Group 2: Valuation Metrics - QSR has a forward P/E ratio of 17.51, significantly lower than CMG's forward P/E of 33.94 [5] - The PEG ratio for QSR is 2.54, while CMG's PEG ratio is higher at 3.86, indicating QSR may be undervalued relative to its expected EPS growth [5] - QSR's P/B ratio stands at 4.44, compared to CMG's P/B ratio of 16.66, further suggesting QSR's relative undervaluation [6] - Based on these valuation metrics, QSR holds a Value grade of B, while CMG has a Value grade of C [6]

Company Performance - Array Technologies, Inc. (ARRY) experienced a decline of 6.7% to $9.33, underperforming the S&P 500's loss of 0.53% on the same day [1] - Over the past month, ARRY shares increased by 17.51%, outperforming the Oils-Energy sector's gain of 1.82% and the S&P 500's gain of 2.06% [1] Earnings Forecast - The upcoming earnings report for Array Technologies is expected to show an EPS of $0, reflecting a 100% decrease from the same quarter last year [2] - Revenue is forecasted at $210.84 million, indicating a 23.4% decline compared to the previous year [2] Full-Year Estimates - Zacks Consensus Estimates project earnings of $0.67 per share and revenue of $1.27 billion for the full year, representing year-over-year changes of +11.67% for earnings and 0% for revenue [3] - Changes in analyst estimates are crucial as they indicate the evolving business trends, with positive revisions suggesting analyst optimism [3][4] Zacks Rank and Valuation - Array Technologies holds a Zacks Rank of 1 (Strong Buy), with the Zacks Consensus EPS estimate increasing by 2.29% over the last 30 days [5] - The company is trading at a Forward P/E ratio of 10.34, which is a discount compared to the industry average of 21.38 [6] - The PEG ratio for ARRY is currently 0.55, compared to the Solar industry's average PEG ratio of 0.67 [6] Industry Context - The Solar industry, part of the Oils-Energy sector, has a Zacks Industry Rank of 24, placing it in the top 10% of over 250 industries [7] - Research indicates that the top 50% rated industries outperform the bottom half by a factor of 2 to 1 [7]

Company Performance - Doximity (DOCS) closed at $41.36, down 5.7% from the previous trading session, underperforming the S&P 500's loss of 0.19% [1] - Over the past month, Doximity shares have decreased by 1.77%, while the Medical sector gained 0.48% and the S&P 500 increased by 2.26% [1] Upcoming Earnings - Doximity is expected to report an EPS of $0.44, a decrease of 2.22% compared to the same quarter last year [2] - Revenue is projected at $181.03 million, reflecting a 7.37% increase from the equivalent quarter last year [2] Annual Forecast - Zacks Consensus Estimates forecast earnings of $1.56 per share and revenue of $645.29 million for the year, indicating increases of 9.86% and 13.13% respectively compared to the previous year [3] - Changes in analyst estimates for Doximity are important as they reflect short-term business trends [3] Analyst Ratings - The Zacks Rank system rates Doximity as 2 (Buy), with a history of outperforming the market, particularly 1 stocks returning an average annual gain of 25% since 1988 [5] - The Zacks Consensus EPS estimate has increased by 0.78% in the past month [5] Valuation Metrics - Doximity has a Forward P/E ratio of 28.04, which is a discount compared to the industry average Forward P/E of 29.42 [6] - The PEG ratio for Doximity is currently 1.48, while the Medical Info Systems industry has an average PEG ratio of 2.33 [6] Industry Context - The Medical Info Systems industry is ranked 160 in the Zacks Industry Rank, placing it in the bottom 35% of over 250 industries [7] - Top-rated industries (top 50%) tend to outperform the bottom half by a factor of 2 to 1 [7]